These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

525 related items for PubMed ID: 28689688

  • 1. Lurasidone in combination with lithium or valproate for the maintenance treatment of bipolar I disorder.
    Calabrese JR, Pikalov A, Streicher C, Cucchiaro J, Mao Y, Loebel A.
    Eur Neuropsychopharmacol; 2017 Sep; 27(9):865-876. PubMed ID: 28689688
    [Abstract] [Full Text] [Related]

  • 2. Lurasidone adjunctive with lithium or valproate for bipolar depression: A placebo-controlled trial utilizing prospective and retrospective enrolment cohorts.
    Suppes T, Kroger H, Pikalov A, Loebel A.
    J Psychiatr Res; 2016 Jul; 78():86-93. PubMed ID: 27089521
    [Abstract] [Full Text] [Related]

  • 3. Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study.
    Loebel A, Cucchiaro J, Silva R, Kroger H, Sarma K, Xu J, Calabrese JR.
    Am J Psychiatry; 2014 Feb; 171(2):169-77. PubMed ID: 24170221
    [Abstract] [Full Text] [Related]

  • 4. Effects on health-related quality of life in patients treated with lurasidone for bipolar depression: results from two placebo controlled bipolar depression trials.
    Rajagopalan K, Bacci ED, Ng-Mak D, Wyrwich K, Pikalov A, Loebel A.
    BMC Psychiatry; 2016 May 23; 16():157. PubMed ID: 27215976
    [Abstract] [Full Text] [Related]

  • 5. Lurasidone Dose Response in Bipolar Depression: A Population Dose-response Analysis.
    Chapel S, Chiu YY, Hsu J, Cucchiaro J, Loebel A.
    Clin Ther; 2016 Jan 01; 38(1):4-15. PubMed ID: 26730454
    [Abstract] [Full Text] [Related]

  • 6. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
    Vieta E, Owen R, Baudelet C, McQuade RD, Sanchez R, Marcus RN.
    Curr Med Res Opin; 2010 Jun 01; 26(6):1485-96. PubMed ID: 20429835
    [Abstract] [Full Text] [Related]

  • 7. LURASIDONE IN THE LONG-TERM TREATMENT OF PATIENTS WITH BIPOLAR DISORDER: A 24-WEEK OPEN-LABEL EXTENSION STUDY.
    Ketter TA, Sarma K, Silva R, Kroger H, Cucchiaro J, Loebel A.
    Depress Anxiety; 2016 May 01; 33(5):424-34. PubMed ID: 26918425
    [Abstract] [Full Text] [Related]

  • 8. Safety and Effectiveness of Long-Term Treatment with Lurasidone in Older Adults with Bipolar Depression: Post-Hoc Analysis of a 6-Month, Open-Label Study.
    Forester BP, Sajatovic M, Tsai J, Pikalov A, Cucchiaro J, Loebel A.
    Am J Geriatr Psychiatry; 2018 Feb 01; 26(2):150-159. PubMed ID: 29146409
    [Abstract] [Full Text] [Related]

  • 9. Lithium vs valproate in the maintenance treatment of bipolar I disorder: A post- hoc analysis of a randomized double-blind placebo-controlled trial.
    Kang MG, Qian H, Keramatian K, Chakrabarty T, Saraf G, Lam RW, Wong H, Yatham LN.
    Aust N Z J Psychiatry; 2020 Mar 01; 54(3):298-307. PubMed ID: 31845587
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of Lurasidone in Adults Aged 55 Years and Older With Bipolar Depression: Post Hoc Analysis of 2 Double-Blind, Placebo-Controlled Studies.
    Sajatovic M, Forester BP, Tsai J, Kroger H, Pikalov A, Cucchiaro J, Loebel A.
    J Clin Psychiatry; 2016 Oct 01; 77(10):e1324-e1331. PubMed ID: 27529375
    [Abstract] [Full Text] [Related]

  • 11. Treatment of bipolar depression: making sensible decisions.
    Citrome L.
    CNS Spectr; 2014 Dec 01; 19 Suppl 1():4-11; quiz 1-3, 12. PubMed ID: 25407667
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study.
    Marcus R, Khan A, Rollin L, Morris B, Timko K, Carson W, Sanchez R.
    Bipolar Disord; 2011 Mar 01; 13(2):133-44. PubMed ID: 21443567
    [Abstract] [Full Text] [Related]

  • 13. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I).
    Young AH, McElroy SL, Bauer M, Philips N, Chang W, Olausson B, Paulsson B, Brecher M, EMBOLDEN I (Trial 001) Investigators.
    J Clin Psychiatry; 2010 Feb 01; 71(2):150-62. PubMed ID: 20122369
    [Abstract] [Full Text] [Related]

  • 14. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
    Sussman N, Mullen J, Paulsson B, Vågerö M.
    J Affect Disord; 2007 Feb 01; 100 Suppl 1():S55-63. PubMed ID: 17383736
    [Abstract] [Full Text] [Related]

  • 15. Lamotrigine adjunctive therapy to lithium and divalproex in depressed patients with rapid cycling bipolar disorder and a recent substance use disorder: a 12-week, double-blind, placebo-controlled pilot study.
    Wang Z, Gao K, Kemp DE, Chan PK, Serrano MB, Conroy C, Fang Y, Ganocy SJ, Findling RL, Calabrese JR.
    Psychopharmacol Bull; 2010 Feb 01; 43(4):5-21. PubMed ID: 21240149
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study.
    Vieta E, T'joen C, McQuade RD, Carson WH, Marcus RN, Sanchez R, Owen R, Nameche L.
    Am J Psychiatry; 2008 Oct 01; 165(10):1316-25. PubMed ID: 18381903
    [Abstract] [Full Text] [Related]

  • 17. Clinical assessment of lurasidone benefit and risk in the treatment of bipolar I depression using number needed to treat, number needed to harm, and likelihood to be helped or harmed.
    Citrome L, Ketter TA, Cucchiaro J, Loebel A.
    J Affect Disord; 2014 Feb 01; 155():20-7. PubMed ID: 24246116
    [Abstract] [Full Text] [Related]

  • 18. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
    McIntyre RS, Konarski JZ, Jones M, Paulsson B.
    J Affect Disord; 2007 Feb 01; 100 Suppl 1():S5-14. PubMed ID: 17391773
    [Abstract] [Full Text] [Related]

  • 19. The effectiveness of lurasidone as an adjunct to lithium or divalproex in the treatment of bipolar disorder.
    Alamo C, López-Muñoz F, García-García P.
    Expert Rev Neurother; 2014 Jun 01; 14(6):593-605. PubMed ID: 24779382
    [Abstract] [Full Text] [Related]

  • 20. One-year rehospitalization rates of patients with first-episode bipolar mania receiving lithium or valproate and adjunctive atypical antipsychotics.
    Woo YS, Bahk WM, Jung YE, Jeong JH, Lee HB, Won SH, Lee KH, Jon DI, Yoon BH, Kim MD, Min KJ.
    Psychiatry Clin Neurosci; 2014 Jun 01; 68(6):418-24. PubMed ID: 24506520
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.